AI-rewritten: This is a summary of an article from Ars Technica, rewritten by AI (Qwen, running locally) to make it easier to read. The facts come from the original article – read it for the full story.

---

The 2024 Nobel Prize in Physiology or Medicine was awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for developing optogenetics, a technique that uses light to control the behavior of specific nerve cells. This method allows scientists to activate or shut down neurons in an intact brain, overcoming the limitations of earlier approaches where cell loss could alter surrounding development. The breakthrough originated from studies of the single-celled algae *Chlamydomonas*, which moves using flagella guided by a light-sensitive eye spot.

Hegemann and Nagel identified genes responsible for light-triggered ion flow in this algae. They discovered proteins called channelrhodopsins, which function like gates that let charged atoms enter or exit the cell when exposed to specific light wavelengths. These proteins use a chemical relative of Vitamin A to detect light, similar to receptors in human eyes. Nagel demonstrated that these genes could work in various organisms, including frog embryos and the nematode worm *C. elegans*, where light exposure altered behavior.

Deisseroth’s team at Stanford adapted these findings for neurons in mammals. They found additional channelrhodopsin variants sensitive to different light colors and developed a version that allows negatively charged ions to enter cells, enabling researchers to selectively shut down nerve activity. By engineering compact light sources and flexible fibers, they created a system capable of operating in freely moving animals. This technology has revolutionized research into memory, sleep, maternal care, and even the restoration of limited light sensing in patients with blindness.